Press Releases
Friends Applauds Senate for FDA User Fee Bill Passage; Urges President Trump to Quickly Sign Into Law
Friends Applauds Senate for FDA User Fee Bill Passage; Urges President Trump to Quickly Sign Into Law Washington, DC – August 3, 2017 – Friends
President Nominates Dr. Norman E. Sharpless as NCI Director
Friends of Cancer Research Applauds This Nomination Washington, DC – June 14, 2017 – President Donald Trump has nominated Dr. Norman E. Sharpless to be
Senate Amendment Seeks to Eliminate Barriers to Clinical Trial Participation
Amendment Provides Opportunity for Patients to More Easily Gain Access to Potentially Beneficial Experimental Therapies While in Development Friends of Cancer Research (Friends) would like
Senate HELP Votes to Move Dr. Scott Gottlieb’s Nomination to Full Senate
Washington, DC, April 27, 2017 – Friends of Cancer Research (Friends) would like to thank Chairman Alexander and the Senate HELP Committee for voting to
Ellen V. Sigal to be Honored at LUNGevity’s Celebration of Hope
Washington, DC, April 20, 2017 – Friends of Cancer Research (Friends) Chairperson & Founder, Ellen V. Sigal, will receive the Face of Hope award at
Senate Confirmation Hearing for FDA Commissioner Nominee Dr. Scott Gottlieb Begins Today 10am ET
Today, at 10am ET, Dr. Scott Gottlieb, the President’s nominee for FDA Commissioner, will appear before the Senate Health, Education, Labor and Pensions (HELP) Committee
Friends Launches ProgressForPatients.org, an Online Learning and Advocacy Community
Washington, DC, March 27, 2017 – Today, Friends of Cancer Research (Friends) launched a new online learning community, ProgressForPatients.org. The site is home to two
Friends of Cancer Research CEO to Testify During First House PDUFA Reauthorization Hearing
The first House PDUFA reauthorization hearing is scheduled to take place at 10:15 am ET today, Wednesday, March 22, 2017, in the U.S. House of
NORD and Friends of Cancer Research Issue Joint Statement In Advance of This Week’s Congressional Hearings on FDA User Fees
Washington, D.C., March 21, 2017—The National Organization for Rare Disorders (NORD) and Friends of Cancer Research, two leading organizations that collectively represent millions of Americans
President Nominates Dr. Scott Gottlieb for FDA Commissioner
President Nominates Dr. Scott Gottlieb for FDA Commissioner Friends Urges Swift Confirmation Washington, DC, March 10, 2017 – Friends of Cancer Research (Friends) strongly supports President Trump’s